Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
Determining the prognostic significance of IKKα in prostate cancer.
Identified crosstalk between IKKα and members of canonical NF-κB pathway in nucleus of HNPC.
»
04/24/20
Clinical and genomic factors associated with seizures in meningiomas.
Patients who undergo radiation and/or have recurrence are at risk for postoperative seizures.
»
04/01/20
The COVID-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020.
Number of referrals for suspected breast cancer 28% lower.
»
08/14/20
Trimodal therapy in muscle invasive bladder cancer management.
Data support trimodal therapy as acceptable bladder sparing strategy.
»
12/02/20
Phytochemicals induce apoptosis by modulation of nitric oxide signaling pathway in cervical cancer cells.
Treatment with phytochemicals elevated NO levels in HeLa cells.
»
12/04/20
ALKBH2 inhibition alleviates malignancy in colorectal cancer by regulating BMI1 -mediated activation of NF-κB pathway
ALKBH2 knockdown also suppressed EMT.
»
12/10/20
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study
Addition of pertuzumab to trastuzumab reduces amount of available plasma membrane HER2 receptor.
»
12/10/20
A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells
Activated T cells redirected to lyse PCa cell lines.
»
12/10/20
Hypoxia and CD11b+ Cell Influx Are Strongly Associated With Lymph Node Metastasis of Oral Cancer.
Localization of CD11b+ cells changed from lymph nodules to medullary sinuses.
»
11/06/20
Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA.
Ac-225-PSMA-617 showed measurable antitumor effect.
»
04/01/20
< Prev
Next >